Biodesix, Inc. (BDSX)
8.13
-0.19
(-2.28%)
USD |
NASDAQ |
Dec 10, 16:00
8.05
-0.08
(-0.98%)
After-Hours: 20:00
Biodesix Shareholders Equity (Quarterly): -1.722M for Sept. 30, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Thermo Fisher Scientific, Inc. | 51.02B |
| FONAR Corp. | 174.87M |
| XWELL, Inc. | -6.333M |
| ProPhase Labs, Inc. | 6.861M |
| Veracyte, Inc. | 1.258B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 88.72M |
| Total Liabilities (Quarterly) | 90.44M |
| Debt to Equity Ratio | -42.35 |
| Current Ratio | 1.840 |
| Net Debt Paydown Yield | -3.74% |